Cite
HARVARD Citation
Sheng, X. et al. (2018). Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study. European journal of cancer. pp. 1-7. [Online].